Report on remission in patients with MS three years after stem cell transplant

Three years after a small number of patients with multiple sclerosis were treated with high-dose immunosuppressive therapy and then transplanted with their own hematopoietic stem cells, most of the patients sustained remission of active relapsing-remitting MS and had improvements in neurological function, according to a study. Three years after a small number of patients with multiple sclerosis were treated with high-dose immunosuppressive therapy and then transplanted with their own hematopoietic stem cells, most of the patients sustained remission of active relapsing-remitting MS and had improvements in neurological function, according to a study published online by JAMA Neurology .

http://ift.tt/1AcMuKI